Company Description
Ariad Pharmaceuticals Incorporated. The Group's principal activities are the discovery and development of medicines that treat cancer by regulating cell signaling with small molecules. The Group's lead product candidate, AP23573, is in multiple ...
More
Related Business Topics
Breaking News
BusinessWeek - November 10, 2009 8:43 AM
11/10/2009 11:10 AM ET 11/10/2009 11:08 AM ET NEW YORK, NY -- (MARKET WIRE) -- 11/10/09 -- iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the ...
Forbes.com - November 10, 2009 5:16 AM
BusinessWire - ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is scheduled to present at the Lazard Capital Markets 6th Annual Healthcare Conference being held at the St. Regis Hotel in New York City, New York. Harvey J. Berger, M.D., ...
Forbes.com - November 10, 2009 5:16 AM
BusinessWire - ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is scheduled to present at the Lazard Capital Markets 6th Annual Healthcare Conference being held at the St. Regis Hotel in New York City, New York. Harvey J. Berger, M.D., ...
Forbes.com - November 10, 2009 5:16 AM
BusinessWire - ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is scheduled to present at the Lazard Capital Markets 6th Annual Healthcare Conference being held at the St. Regis Hotel in New York City, New York. Harvey J. Berger, M.D., ...
Forbes.com - November 09, 2009 8:27 AM
(For large-cap stocks on the move, click on) Nov 9 (Reuters) - Some small and midcap stocks on the move on Monday: XENOPORT INC, $17.88, down 1 pct The company and its partner GlaxoSmithkline Plc said on Friday the U.S. FDA has extended the review date ...
Harvard Business School
Leadership & Strategy Program for Pharma & Biotech Executives.
www.exed.hbs.edu
Leadership & Strategy Program for Pharma & Biotech Executives.
www.exed.hbs.edu
